Back to catalogue
№ 145 30 filings · 2021-05-13 → 2026-04-28

OCADO GROUP PLC

OCDO
Personal Care, Drug and Grocery Stores Market cap £1.7bn Overall fit 410 /1000

Strong operating leverage and a fair-to-cheap valuation are partly offset by an indirect (not direct) AI angle and a leveraged, refinancing-exposed balance sheet that limits downside protection.

Fair value range 150p–280p Mid case · £1.8bn
Absolute upside +5.6% vs current market cap
Conviction 3/5 confidence in fair call
Supports the call
  • Detailed segmental disclosure with consistent operating KPIs
  • Two consecutive guidance raises in FY24 (Technology Solutions margin and cash flow)
  • Technology Solutions now scaled enough to anchor SOTP valuation
Limits the call
  • Wide valuation range driven by uncertain partner module ramp
  • Refinancing of £1.45bn of debt 2025-27 could force equity raise
Methodology

Sum-of-parts with EV/EBITDA cross-check

In one line · bull case

Technology Solutions is finally inflecting with mid-teens EBITDA margin, high operating leverage and a credible mid-term path to cash positive, available at a market cap that does not require the bull case to be right.

In one line · biggest risk

£1.45bn of debt matures between Dec-2025 and Jan-2027 and refinancing at materially higher coupons (or a forced equity raise) could compress equity value before the operating leverage story plays out.

Drivers
AI beneficiary 35 /100
Robotics/automation platform with embedded ML, but sells to grocers rather than into the AI buildout itself.
Operating leverage 78 /100
71% contribution margin on Technology Solutions; large fixed support/tech cost base; capacity already paid for.
Earnings vs expectations 60 /100
Two consecutive beats and raises in FY24 reverses prior multi-year pattern of disappointing partner ramps.
Growth momentum 65 /100
Technology Solutions revenue +22% in 1H24, Retail +11-17%, group EBITDA trajectory accelerating.
Moat 65 /100
Proprietary OSP platform with deep IP, partner exclusivity and 20+ years of R&D; AutoStore IP wins reinforce defensibility.
Earnings quality 45 /100
Heavy internal-cost capitalisation; large adjusting items (insurance, contingent consideration); EBITDA positive but FCF still negative.
Management quality 50 /100
Founder-led, technically credible, but historic pattern of overpromising on partner roll-out and an 80%+ share price drawdown from 2022 placing.
Cyclicality 30 /100
Predominantly defensive grocery exposure plus recurring tech fees; modest cyclicality.
Leverage 75 /100
Net debt £1.22bn vs run-rate EBITDA ~£170m; concentrated 2025-27 maturity wall a key risk.
Value-trap signals · 4
  • Contingent consideration from M&S written down from £156m to £28m as Ocado Retail missed Target
  • Module orders flat YoY at 232 with no net new orders in 1H24
  • Sobeys CFC4 Vancouver paused post-1H24
  • Heavy capitalisation of internal development costs supports headline EBITDA but not FCF

Ocado Group PLC (OCDO) — Investment Research Note

Executive summary

Ocado Group is a UK-listed grocery technology company operating through three segments: Technology Solutions (selling the proprietary Ocado Smart Platform — OSP — to 13 international grocery partners on a managed-service basis), Ocado Logistics (a UK third-party fulfilment business serving its two domestic partners), and a 50% stake in Ocado Retail (its consumer-facing UK online grocer, JV with M&S). Across the five-year window, the business has progressed from a £74m group EBITDA loss in FY22 to a £52m profit in FY23 and £71m of EBITDA in just the first half of FY24, driven by Technology Solutions revenue more than tripling as international CFC go-lives accelerated, with management guiding to mid-FY26 cash flow positive 2024-07 half-year. The single most important point for valuation today is whether Technology Solutions can scale its module count and convert it into the mid-term ambition of high-teens contribution margin and >£600m revenue without a further dilutive equity raise to bridge debt maturities clustered in late-2025 through January 2027.

Fair value estimate

Range: 150–280p per share (implied market cap range £1,263m – £2,358m, midpoint ~£1,810m).

Methodology — sum-of-parts (SOTP), cross-checked against forward EV/EBITDA:

  • Technology Solutions: mid-term EBITDA target supported by 1H24 actuals (£35m EBITDA on £241m revenue, 15% margin, ahead of "greater than 10%" prior guidance). Assume FY26 EBITDA of £100–150m at 12–18x EV/EBITDA → £1.2–2.7bn.
  • Ocado Logistics: stable cost-plus 3PL, ~£30m EBITDA at 8x → £240m.
  • Ocado Retail (50%): FY24 guidance c.2.5% EBITDA margin on ~£2.7bn revenue → ~£67m share of EBITDA; valued at 7–10x → £200–340m. M&S contingent consideration valuation now £28m on the balance sheet, well below the £190.7m headline payable 2024-07 half-year.
  • Less net debt: £1,222m at 1H24 (gross debt £1,969m including leases).
  • Equity value: £1,260m – £2,360m.

Compared to the latest disclosed market cap of £1,658.7m, this implies absolute upside/downside of -24% to +42%, midpoint +9%. View: fair, with significant valuation skew toward the upside scenario where Re:Imagined economics translate into faster module ramp.

Sector context

  • Confirmed sector: Personal Care, Drug and Grocery Stores (Consumer Staples), though Ocado is atypical — most group EBITDA contribution comes from technology licensing rather than physical grocery margins.
  • Quality/growth/leverage profile is above the sector on growth, well below on quality and leverage vs typical staples peers. Net debt/run-rate EBITDA is >7x; staples peers are generally <2x.
  • Closest UK listed analogues: Marks & Spencer Group (MKS) as the Ocado Retail JV partner and grocery comparable; Sainsbury's (SBRY) and Tesco (TSCO) as pure-play UK grocers. Internationally, the closest model parallel is AutoStore (AUTO NO) — Ocado's litigation counterparty — and Symbotic (SYM US) in warehouse automation.

Investment thesis (3 bullets)

  • Technology Solutions is finally inflecting: revenue +22% to £241m in 1H24, EBITDA more than doubled to £35m with contribution margin of 71%, and FY24 EBITDA margin guidance raised twice — from ">10%" to "mid-teens %". Live module count grew 11% to 112, with capacity at 24 actively-trading sites. Capital expenditure already incurred underpins a path to >£8bn of partner gross annual sales 2024-02 final results.
  • Strong operating leverage as platform amortises across a wider partner base: support costs are being progressively reduced toward a £150m target (~£180m FY24), total technology spend guided lower (£290m FY24 → £240m FY26), and direct operating costs on OSP CFCs improved 20bps to 1.56% of sales capacity. The Re:Imagined hardware suite (600-series bots, OGRP, AFL) is now being deployed and is expected to drive labour productivity above 300 UPH and >70% contribution margin 2024-07 half-year, 2024-02 final results.
  • Cash burn improving sharply, with credible path to cash-positive FY26: underlying cash outflow improved by £356m in FY23 and a further £101m in 1H24 to £(197)m, with FY24 guidance raised again to a £150m improvement vs FY23. Group has £1,047m of liquidity (including £300m undrawn RCF). The cash flow trajectory de-risks the FY25/26/27 debt maturity wall 2024-07 half-year.

Key risks (3 bullets)

  • Partner ramp-up has consistently disappointed: Sobeys' CFC4 in Vancouver paused (announced 20 June 2024), Casino requiring a >£15m partial impairment, Kindred revenues materially below acquisition case. The OSP business model depends on partners actually filling capacity — and many haven't. Module orders are currently flat year-on-year at 232 2024-07 half-year.
  • Refinancing concentration risk: £600m convertible matures Dec 2025, £500m senior unsecured notes Oct 2026, £350m convertible Jan 2027. Coupons on refinancing will be materially higher than current ~0.75–3.9%. Management has stated "preference not to issue equity in the near term", but the 2022 placing at 795p (today's price implies a ~75% loss for placees) shows the company will tap equity when forced 2024-07 half-year.
  • AutoStore litigation overhang largely resolved but IP/manufacturing concentration remains: AutoStore settlement of £200m booked as exceptional income is positive, but Ocado's robotics IP is still being defended in multiple jurisdictions, and the platform depends on continued partner exclusivity — a risk if commodity AutoStore-equivalent solutions become "good enough" at lower cost 2024-02 final results.

Operating leverage

Technology Solutions is the embodiment of high operating leverage in this group. Contribution margin was 71% in 1H24 (unchanged YoY) with direct operating costs running at 1.56% of installed sales capacity. The cost base above contribution is largely fixed: support costs of £90m in 1H24 (declining); technology costs of £47m (declining). Of the FY24 total Technology Solutions revenue (guided 15–20% growth to ~£430m), each incremental £100m of fee revenue at 71% contribution margin yields ~£71m of EBITDA against essentially flat cost-base growth. If the 232 modules already ordered translate into >£16bn of partner sales through OSP in the mid-term (per management), and Ocado captures ~5.5% of that in capacity fees, recurring Technology Solutions revenue could approach ~£900m — at high incremental margin. Re:Imagined is the inflection point: labour productivity is targeted to lift from 220 UPH today to >300 UPH, and management explicitly expects 70%+ contribution margin on Re:Imagined CFCs 2024-07 half-year, 2024-02 final results.

Value-trap signals

  • Repeated reduction of contingent consideration receivable from M&S: from £156m to £95m (FY23) and then £28m (1H24) — Ocado Retail consistently missed the original Target.
  • Modules ordered flat at 232 across the entire 1H24 period — no net new orders from any partner.
  • Heavy capitalisation of internal development costs (£100m+ in 1H24 alone capitalised to intangibles) sustains a depreciation tailwind to reported EBITDA that does not yet show up as free cash flow.
  • Sobeys CFC4 pause post-balance-sheet (Vancouver) is the most recent example of a structural pattern of partner delays.

Earnings vs. expectations

  • FY23 final results (Feb 2024): management delivered "in line or better than guidance" — Group adjusted EBITDA of £52m exceeded the guided "positive" target; cash flow improvement of £356m vs guidance of £200m. Beat.
  • 1H24 (Jul 2024): Technology Solutions EBITDA margin guidance raised from ">10%" to "mid-teens %"; underlying cash flow improvement raised from £100m to £150m for FY24. Strong beat and raise.
  • Ocado Retail Q3 2024 trading update (Sep 2024): revenue guidance raised from mid-high single digits to low-double-digit growth. Beat and raise.
  • Ocado Retail Q4/FY24 trading update (Jan 2025): full-year retail revenue +13.9% to £2,686m; Q4 +17.5% — the fastest-growing UK grocer. Beat.

Pattern: trading is in an upward inflection on the operating side after years of disappointing partner ramps. Three consecutive beats/raises across FY23–FY24 reverse a prior multi-year pattern of guidance disappointment.

Conviction

Conviction: 3 (moderate).

Anchors: (1) Detailed segmental disclosure with consistent KPIs (modules, UPH, contribution margin); (2) clear, recently-raised forward guidance from management that has been met in the past two reporting cycles; (3) Technology Solutions financials are now substantial enough to anchor a valuation independently of Retail/Logistics.

Caveats: (1) The valuation range is wide (£1.3–2.4bn) because Technology Solutions terminal EBITDA depends on partner behaviour that has been historically unpredictable; (2) refinancing risk over the next 18 months could compress equity value materially if it triggers a placing, and that scenario is not fully reflected in either base-case or upside.

Driver scoring

  • AI beneficiary (35): Ocado uses ML/robotics/AI internally for OSP optimisation and is a partial automation play, but it sells to grocers — not into the AI buildout. Re:Imagined is a robotics story, not an AI-receiver story.
  • Operating leverage (78): One of the strongest operating leverage profiles in the UK market — 71% contribution margin on Technology Solutions, large fixed support cost base, capacity-build already paid for.
  • Valuation: implies fair-to-modestly-cheap given the range.
Filings consulted · 31

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-04-28Result OF Agm2026-04-28_9542490_result-of-agm.md0.30
  2. 2025-07-17Half Year Results2025-07-17_8983526_half-year-results.md0.77
  3. 2025-04-29Result OF Agm2025-04-29_8852418_result-of-agm.md0.20
  4. 2025-02-27Final Results2025-02-27_8754635_final-results.md0.65
  5. 2025-01-14Trading Statement2025-01-14_8686471_trading-statement.md0.55
  6. 2024-09-19Trading Statement2024-09-19_8424511_trading-statement.md0.55
  7. 2024-07-16Half Year Report2024-07-16_8312559_half-year-report.md0.58
  8. 2024-04-29Result OF Agm2024-04-29_8162752_result-of-agm.md0.14
  9. 2024-03-26Trading Statement2024-03-26_8106091_trading-statement.md0.38
  10. 2024-02-29Notice OF Agm2024-02-29_8064438_notice-of-agm.md0.14
  11. 2024-02-29Final Results2024-02-29_8062241_final-results.md0.45
  12. 2024-01-16Trading Statement2024-01-16_7990502_trading-statement.md0.38
  13. 2023-09-19Trading Statement2023-09-19_7763254_trading-statement.md0.38
  14. 2023-07-18Half Year Report2023-07-18_7638246_half-year-report.md0.41
  15. 2023-05-02Result OF Agm2023-05-02_7509358_result-of-agm.md0.07
  16. 2023-03-28Trading Statement2023-03-28_7335702_trading-statement.md0.21
  17. 2023-02-28Notice OF Agm2023-02-28_7281291_notice-of-agm.md0.07
  18. 2023-02-28Final Results2023-02-28_7237701_final-results.md0.25
  19. 2023-01-17Trading Statement2023-01-17_7439805_trading-statement.md0.21
  20. 2022-09-13Trading Statement2022-09-13_7311897_trading-statement.md0.21
  21. 2022-07-21Half Year Report2022-07-21_7083019_half-year-report.md0.23
  22. 2022-06-20Proposed Placing Retail Offer And Financing2022-06-20_7021410_proposed-placing-retail-offer-and-financing.md0.17
  23. 2022-05-25Trading Statement2022-05-25_6977318_trading-statement.md0.21
  24. 2022-05-04Result OF Agm2022-05-04_7192451_result-of-agm.md0.07
  25. 2022-03-17Trading Statement2022-03-17_6968408_trading-statement.md0.21
  26. 2022-02-11Notice OF Agm2022-02-11_6803152_notice-of-agm.md0.07
  27. 2022-02-08Final Results2022-02-08_6749185_final-results.md0.25
  28. 2021-12-14Trading Statement2021-12-14_6829807_trading-statement.md0.21
  29. 2021-09-14Trading Statement2021-09-14_6825482_trading-statement.md0.21
  30. 2021-07-06Half Year Report2021-07-06_6536722_half-year-report.md0.23
  31. 2021-05-13Result OF Agm2021-05-13_6373847_result-of-agm.md0.03

This research note was authored by a large language model after reading 30 regulatory filings published between 2021-05-13 and 2026-04-28. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.